MetaCap

GridAI Technologies (GRDX) vs Veru (VERU)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

GridAI Technologies (GRDX) has outperformed Veru (VERU) over the past year, gaining 20.6% versus a loss of 12.6%. Over five years, VERU leads with a -97.5% price change compared with -100.0% for GRDX. Veru is the larger company by market cap ($33.1 million vs $32.4 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GRDX+20.61%VERU-12.61%
+169%+68%-33%
Nov 21, 20251 yearNov 20, 2026
GRDX-99.99%VERU-97.52%
+156%+22%-112%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GRDX versus VERU key metrics
MetricGRDXVERU
Share price$3.16$1.94
Market cap$32.44M$33.08M
1-day change-8.41%-8.06%
YTD return-32.19%-9.35%
1-year return+20.61%-12.61%
5-year return-99.99%-97.50%
EPS (TTM)$-5.65$-0.61
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$36.25K—
Net income (latest FY)$-6.39M$-22.73M
Gross margin-1813.56%—
Operating margin-19539.98%—
Net margin-17634.42%—
52-week high$6.93$7.33
52-week low$1.87$1.93
Distance from 52-week high-54.39%-73.53%
Analyst consensus—strong_buy
Avg. price target upside—+1223.20%
Average volume120.78K193.35K
Shares outstanding10.27M17.05M
Employees—20
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • GRDX has outperformed VERU by 33.2 percentage points over the past year.

About GridAI Technologies

GRDX stock →

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.

Health Care · Biotechnology: Pharmaceutical Preparations

About Veru

VERU stock →

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.

Health Care · Biotechnology: Pharmaceutical Preparations · 20 employees

GRDX vs VERU FAQ

Which is bigger, GridAI Technologies or Veru?

Veru (VERU) is larger, with a market capitalization of $33.08M compared with $32.44M for GridAI Technologies (GRDX).

Which stock has performed better over the past year, GRDX or VERU?

GRDX returned +20.61% over the past 12 months, compared with -12.61% for VERU (price return, excluding dividends). Past performance does not predict future results.

Are GridAI Technologies and Veru in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons